tiprankstipranks
Trending News
More News >
Biosyent Inc (TSE:RX)
:RX
Canadian Market

Biosyent (RX) Income Statement

Compare
49 Followers

Biosyent Income Statement

Last quarter (Q4 2024), Biosyent's total revenue was C$8.80M, an increase of 6.32% from the same quarter last year. In Q4, Biosyent's net income was C$1.61M. See Biosyent’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 35.03MC$ 31.59MC$ 27.93MC$ 28.62MC$ 22.33M
Gross Profit
C$ 27.86MC$ 25.60MC$ 22.86MC$ 22.64MC$ 17.42M
Operating Expenses
C$ 19.10MC$ 18.13MC$ 15.95MC$ 14.39MC$ 12.30M
Depreciation and Amortization
C$ 589.95KC$ 455.34KC$ 451.00KC$ 457.11KC$ 510.42K
EBITDA
C$ 10.43MC$ 9.06MC$ 7.96MC$ 8.92MC$ 5.84M
Operating Income
C$ 8.75MC$ 7.47MC$ 6.98MC$ 8.18MC$ 5.03M
Other Income/Expenses
C$ 1.03MC$ 1.06MC$ 448.65KC$ 195.22KC$ 206.96K
Pretax Income
C$ 9.78MC$ 8.53MC$ 7.43MC$ 8.38MC$ 5.24M
Net Income
C$ 7.27MC$ 6.46MC$ 5.46MC$ 6.28MC$ 3.80M
Per Share Metrics
Basic EPS
C$ 0.63C$ 0.54C$ 0.44C$ 0.50C$ 0.29
Diluted EPS
C$ 0.62C$ 0.53C$ 0.44C$ 0.49C$ 0.29
Weighted Average Shares Outstanding
11.59M 11.95M 12.30M 12.69M 13.00M
Weighted Average Shares Outstanding (Diluted)
11.81M 12.17M 12.54M 12.87M 13.09M
Currency in CAD

Biosyent Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis